
Our proposed model shows that, hepatitis B virus “C protein” binds to membrane docking protein, while “X protein” and “P protein” interacts with cell-killing and metabolic process proteins, respectively.Ĭitation: Barman RK, Saha S, Das S (2014) Prediction of Interactions between Viral and Host Proteins Using Supervised Machine Learning Methods. In addition, unknown potential targets of hepatitis B virus-human and hepatitis E virus-human PPIs have been predicted through proposed SVM model and validated by gene ontology enrichment analysis. The proposed SVM-based method was evaluated on blind dataset and attained a sensitivity of 64%, specificity of 83%, and accuracy of 74%. Overall, the SVM and Random Forest achieved accuracy of 71% and 72.41%, respectively. However the specificity of Naïve Bayes was the highest (99.52%) as compared with SVM (74%) and Random Forest (89.08%). In this study, SVM-based method achieved better sensitivity of 67% over Naïve Bayes (37.49%) and Random Forest (55.66%). Let us know how this access is important for you.Out of 44 descriptors, best features were found to be domain-domain association and methionine, serine and valine amino acid composition of viral proteins. Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Future work should elucidate further region-specific gene-environment interactions and whether alternate polymorphisms may be associated with efavirenz metabolism. Efavirenz-metabolizing allele patterns are strongly associated with risk of incident depression. However, in analyses restricted to participants without pre-ART depression, poorer CYP2B6 metabolism was associated with increased odds of depression (adjusted odds ratio, 4.11 95% CI, 1.04-16.20). CYP2B6 metabolizer strata did not have a statistically significant association with either depression or 6-month viral suppression (aRR, 1.01 95% CI, 0.88-1.15). Eighty-five percent (167/202) of participants who completed a 6-month visit achieved viral suppression. Seven percent (56/242) of follow-up visits met criteria for depression. Participants were classified as normal (32%), intermediate (50%), and poor (18%) metabolizers. Among 242 participants, there were no differences in the pre-ART depression or viral load by efavirenz metabolism strata (p > .05). We fit generalized estimating equation and modified Poisson regression models adjusted for demographic, clinical, and psychosocial characteristics with or without individuals with depression at the time of ART initiation. Our outcomes were probable depression in the first 2 years after antiretroviral therapy (ART) initiation (mean score of >1.75 on the Hopkins Symptom Depression Checklist) and viral suppression 6 months after ART initiation. To define exposure, we used previously published pharmacokinetic modeling data to categorize participants as normal, intermediate, and poor efavirenz metabolizers. We evaluated three SNPs in CYP2B6 (rs3745274, rs28399499, and rs4803419) in Ugandan persons living with HIV.

Single-nucleotide polymorphisms (SNPs) in CYP2B6 have been shown to predict variation in plasma efavirenz concentrations, but associations between these SNPs and efavirenz-mediated depression and viral suppression are less well described.
